{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:47:13Z","timestamp":1782132433452,"version":"3.54.5"},"reference-count":14,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Outcomes of treatment for patients with Lupus have shown overall improvement\nand benefit from the more aggressive use of immunosuppressants and biological agents\nthrough a treat-to-target approach. However, chronic musculoskeletal pain can be refractory to\ntreatment despite the use of non-steroidal anti-inflammatory drugs, corticosteroids, and other analgesic\nagents, leading to patient dissatisfaction. The concept of new neural pathways from psilocybin\nusage has been proposed in a variety of pain syndromes; however, it is not trialed for patients\nwith Lupus pain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation:<\/jats:title>\n<jats:p>The patient was a 67-year-old male with positive anti-dsDNA antibody Lupus\nwith a predominance of chronic polyarticular joint pain treated with hydroxychloroquine and non-steroidal\nanti-inflammatory drugs without pain relief. Pain dramatically improved after a one-time\nmacro-dosing of 6 grams of Psilocybin cubensis in Oregon, which he expected would only provide\na sense of enlightenment. After 12 months, he continued without debilitating joint pain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The serotonin-2A receptor\u2019s activation triggers an array of neurophysiological reactions\nthat disrupt the functional connections in areas of the brain that are associated with chronic\npain. These neuroplastic effects can generate healthy connections, resulting in long-lasting pain relief.\nHowever, this is a process that has not been fully analyzed. While there is anecdotal evidence\nto suggest the therapeutic benefits for autoimmune diseases, including rheumatoid arthritis and psoriasis,\nthere is no specific research that explores its use for lupus-related pain. Since this is the first\ncase that shows the benefit of psilocybin in a patient with Lupus, further studies on macro-dosing\npsilocybin to treat Lupus pain are warranted.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397119666230904150750","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T05:48:50Z","timestamp":1693979330000},"page":"97-99","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential Benefits of Psilocybin for Lupus Pain: A Case Report"],"prefix":"10.2174","volume":"20","author":[{"given":"Sofia Audrey B.","family":"Gonzales","sequence":"first","affiliation":[{"name":"Department of Rheumatology, University of Southern California, 1520 San Pablo St Los Angeles, CA90033-5310,\nUnited States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Alexopoulos","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Southern California, 1520 San Pablo St Los Angeles, CA90033-5310,\nUnited States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Arkfeld","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Southern California, 1520 San Pablo St Los Angeles, CA90033-5310,\nUnited States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Ghlichloo I.","unstructured":"Ghlichloo I.; Gerriets V.; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Florida: StatPearls"},{"key":"ref=2","first-page":"24","volume":"18","author":"Marcum Z.A.","year":"2010","unstructured":"Marcum Z.A.; Hanlon J.T.; Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 2010,18(9),24-27","journal-title":"Ann Longterm Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/03602532.2016.1278228","volume":"49","author":"Dinis-Oliveira R.J.","year":"2017","unstructured":"Dinis-Oliveira R.J.; Metabolism of psilocybin and psilocin: Clinical and forensic toxicological relevance. Drug Metab Rev 2017,49(1),84-91","journal-title":"Drug Metab Rev"},{"key":"ref=4","doi-asserted-by":"publisher","author":"Aronson J.K.","unstructured":"Aronson J.K.;  Manson's Tropical Infectious Diseases. Amsterdam: Elsevier Limited 2014.","DOI":"10.1016\/B978-0-7020-5101-2.00077-7"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3390\/molecules26102948","volume":"26","author":"Lowe H.","year":"2021","unstructured":"Lowe H.; Toyang N.; Steele B.; Valentine H.; Grant J.; Ali A.; Ngwa W.; Gordon L.; The therapeutic potential of psilocybin. Molecules 2021,26(10),2948","journal-title":"Molecules"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"Madsen M.K.","year":"2019","unstructured":"Madsen M.K.; Fisher P.M.; Burmester D.; Dyssegaard A.; Stenb\u00e6k D.S.; Kristiansen S.; Johansen S.S.; Lehel S.; Linnet K.; Svarer C.; Erritzoe D.; Ozenne B.; Knudsen G.M.; Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology 2019,44(7),1328-1334","journal-title":"Neuropsychopharmacology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.37275\/amcr.v1i2.7","volume":"1","author":"Kusumadewi A.F.","year":"2021","unstructured":"Kusumadewi A.F.; Case report: magic mushroom (psilocybe cubensis) intoxication. Archives of The Medicine and Case Reports 2021,1(2),31-34","journal-title":"Archives of The Medicine and Case Reports"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"Shao L.X.","year":"2021","unstructured":"Shao L.X.; Liao C.; Gregg I.; Davoudian P.A.; Savalia N.K.; Delagarza K.; Kwan A.C.; Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 2021,109(16),2535-2544.e4","journal-title":"Neuron"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/13554794.2018.1468469","volume":"24","author":"Ramachandran V.","year":"2018","unstructured":"Ramachandran V.; Chunharas C.; Marcus Z.; Furnish T.; Lin A.; Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF). Neurocase 2018,24(2),105-110","journal-title":"Neurocase"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jox12010004","volume":"12","author":"Coppola M.","year":"2022","unstructured":"Coppola M.; Bevione F.; Mondola R.; Psilocybin for treating psychiatric disorders: A psychonaut legend or a promising therapeutic perspective? J Xenobiot 2022,12(1),41-52","journal-title":"J Xenobiot"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/02698811211073759","volume":"36","author":"Gukasyan N.","year":"2022","unstructured":"Gukasyan N.; Davis A.K.; Barrett F.S.; Cosimano M.P.; Sepeda N.D.; Johnson M.W.; Griffiths R.R.; Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. J Psychopharmacol 2022,36(2),151-158","journal-title":"J Psychopharmacol"},{"key":"ref=12","first-page":"698","volume":"64","author":"Lyes M.","year":"2022","unstructured":"Lyes M.; Yang K.H.; Castellanos J.; Furnish T.; Microdosing psilocybin for chronic pain: A case series. Pain 2022,64(4),698-702","journal-title":"Pain"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.9740\/mhc.2017.01.024","volume":"7","author":"Daniel J.","year":"2017","unstructured":"Daniel J.; Haberman M.; Clinical potential of psilocybin as a treatment for mental health conditions. Ment Health Clin 2017,7(1),24-28","journal-title":"Ment Health Clin"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mmcr.2018.12.007","volume":"23","author":"Austin E.","year":"2019","unstructured":"Austin E.; Myron H.S.; Summerbell R.K.; Mackenzie C.A.; Acute renal injury cause by confirmed Psilocybe cubensis mushroom ingestion. Med Mycol Case Rep 2019,23,55-57","journal-title":"Med Mycol Case Rep"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397119666230904150750","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220687\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397119666230904150750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:33:36Z","timestamp":1706182416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220687\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397119666230904150750","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}